Metraipolis › archive › dc_dc86112db427

Circulating tumor DNA as a biomarker for progression and survival in esophageal cancer after neoadjuvant therapy and esophagectomy: a systematic review and… — Europe PMC PMID:40793951

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40793951
DOI
10.1097/js9.0000000000003017
License (as archived)
solo-consultazione
Archived
2026-10-06T20:11:48.399Z
SHA-256 of the archived text
303796a2de9b4616a34c1c56c389709dab25cb0909be781c750712c9b5e19d36
Stable URL of this page
https://metraipolis.com/documento/dc_dc86112db427

How to cite

Circulating tumor DNA as a biomarker for progression and survival in esophageal cancer after neoadjuvant therapy and esophagectomy: a systematic review and… — Europe PMC PMID:40793951 — Europe PMC (en), https://europepmc.org/article/MED/40793951 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_dc86112db427 (Metraipolis archive dc_dc86112db427, sha256 303796a2de9b4616a34c1c56c389709dab25cb0909be781c750712c9b5e19d36)
BibTeX
@misc{dcdc86112db427,
  title = {Circulating tumor DNA as a biomarker for progression and survival in esophageal cancer after neoadjuvant therapy and esophagectomy: a systematic review and… — Europe PMC PMID:40793951},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40793951},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_dc86112db427; sha256 303796a2de9b4616a34c1c56c389709dab25cb0909be781c750712c9b5e19d36},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40793951. Agents can read the archived copy with the MCP tool read_document.